blood-thinner

Pfizer was another top blue-chip performer, gaining 3.7% after positive results of a blood-thinner study.

Dow Surges 254, Nearing Break-Even Point for Year Brendan Conway 2011

The analysis involved more than 30,000 patients and compared those on Pradaxa to others in control groups, who received another blood-thinner like warfarin or enoxaparin, or a placebo.

Study Finds Risk in New Stroke Drug Jennifer Corbett Dooren 2012

Paris-based Sanofi, like most of its peers, is suffering from generic competition as many of its top-selling medicines, such as blood-thinner Lovenox and cancer treatment Taxotere, have lost patent protection.

Sanofi Raises Forecast Goran Mijuk 2011

This was not wholly unexpected—hemorrhaging is an unavoidable risk of the blood-thinner Brie had to be given so long as she was hooked up to the ECMO machine—and there was still a chance that Brie might escape any permanent damage.

The Panic Virus Seth Mnookin 2011

This month, its best pipeline hope, blood-thinner Brilinta, gained U.S. approval, adding a potential $1.5 billion to $3.5 billion onto 2014 sales.

AstraZeneca Still Falling Behind Rivals Hester Plumridge 2011

Last March, U.S. regulators stipulated the label of blood-thinner Plavix, one of the world's top-selling drugs, be changed to state it works well only in patients with a certain genetic makeup.

Pharmaceutical Sector Remains Genetically Challenged Hester Plumridge 2011

Sanofi SA contributed more than $5 million to two medical groups and a medical researcher that encouraged U.S. regulators to delay approval of a drug that would undercut the company's blockbuster blood-thinner Lovenox, according to a new report from the Senate Finance Committee.

Senate Panel Hits Sanofi Payments Alicia Mundy 2011

Sanofi contributed more than $5 million to two medical groups and a medical researcher that encouraged U.S. regulators to delay approval of a drug that would undercut the company's blockbuster blood-thinner Lovenox, said a new report from the U.S. Senate Finance Committee.

What's News 2011

French drug giant Sanofi SA, too, expects to wring $1 billion in world-wide sales for its blood-thinner Plavix—once a $9 billion drug—after it loses U.S. patent protection in May.

Helping Lipitor Live Longer Jonathan D. Rockoff 2011

This was not wholly unexpected—hemorrhaging is an unavoidable risk of the blood-thinner Brie had to be given so long as she was hooked up to the ECMO machine—and there was still a chance that Brie might escape any permanent damage.

The Panic Virus Seth Mnookin 2011